Giuseppe Mazza
Founder at Mazza Innovation Ltd.
Profile
Giuseppe Mazza is associated with two companies, Mazza Innovation Ltd.
and Engitix Ltd.
He is the founder of both companies.
At Mazza Innovation Ltd., he holds the title of Director starting from 2011.
At Engitix Ltd., he holds the title of Chief Executive Officer & Director starting from 2016.
Giuseppe Mazza active positions
| Companies | Position | Start |
|---|---|---|
Mazza Innovation Ltd.
 Mazza Innovation Ltd. Food: Specialty/CandyConsumer Non-Durables Mazza Innovation Ltd. provides plant extraction technology. Its products include PhytoClean which yields clean ingredients in an earth-friendly manner from plants. The company was founded by Giuseppe Mazza, Carl Pronyk, and Eduardo Cacace in August 2011 and is headquartered Delta, Canada. | Founder | 2011-07-31 |
Engitix Ltd.
 Engitix Ltd. Miscellaneous Commercial ServicesCommercial Services Engitix Ltd. is a preclinical stage biopharma British company that is developing breakthrough therapies for fibrosis and solid tumors using its patient-centric human extracellular matrix drug discovery platform. The company has drug discovery partnerships with Dompe Farmaceutici and Takeda for advanced fibrotic liver diseases and fibrostenotic inflammatory bowel disease. Engitix was established in 2016 to commercialize research from the Institute for Liver and Digestive Health at University College London. The company is headquartered in WestWorks, London, UK. Giuseppe Mazza and Massimo Pinzani founded the company, and Giuseppe Mazza has been the CEO since 2016. | Founder | 2015-12-31 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Mazza Innovation Ltd.
Mazza Innovation Ltd. Food: Specialty/CandyConsumer Non-Durables Mazza Innovation Ltd. provides plant extraction technology. Its products include PhytoClean which yields clean ingredients in an earth-friendly manner from plants. The company was founded by Giuseppe Mazza, Carl Pronyk, and Eduardo Cacace in August 2011 and is headquartered Delta, Canada. | Consumer Non-Durables |
Engitix Ltd.
Engitix Ltd. Miscellaneous Commercial ServicesCommercial Services Engitix Ltd. is a preclinical stage biopharma British company that is developing breakthrough therapies for fibrosis and solid tumors using its patient-centric human extracellular matrix drug discovery platform. The company has drug discovery partnerships with Dompe Farmaceutici and Takeda for advanced fibrotic liver diseases and fibrostenotic inflammatory bowel disease. Engitix was established in 2016 to commercialize research from the Institute for Liver and Digestive Health at University College London. The company is headquartered in WestWorks, London, UK. Giuseppe Mazza and Massimo Pinzani founded the company, and Giuseppe Mazza has been the CEO since 2016. | Commercial Services |
- Stock Market
- Insiders
- Giuseppe Mazza
